In 2020, COVID-19 (SARS-CoV-2 virus) was declared a pandemic by the world health organization (WHO). Neutralizing antibodies are an essential research avenue for COVID-19 therapeutics, as these specific defense antibodies can bind to various parts of the virus (such as receptors or the viral capsid) and prevent infections. The key to the development of successful therapeutics, therefore, relies on further research into the mechanisms underlying viral infections.
Download this infographic to learn about:- Investigating host-virus interactions
- Neutralization antibody assessments
- Immune response assessments
